DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials

by Waguih William IsHak, MD, FAPA; Paloma Garcia, BS Candidate; Rachel Pearl, MD; Jonathan Dang, MD; Catherine William, BS; Jayant Totlani, BS, DO candidate; and Itai Danovitch, MD, MBA Drs.

Seizure and Other Catastrophes due to Bupropion Overdose: Recent Case Report and Review of Published Cases

by Isha Snehal, MD; Garret Lorenzen, MS; and Ashish Sharma, MD Dr. Snehal is with Department of Neurological Sciences, University of Nebraska Medical Center in Omaha, Nebraska. Mr. Lorenzen is

Risk Management: Treating Patients at Risk for Suicide: Part 1

by Donna Vanderpool, MBA, JD Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures:

Letter to the Editor: What About the Hippotherapy Benefit-cost Ratio in Everyday Clinical Practice? The Physician Point of View

Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2023;20(4–6):8.

Remote Cognitive Therapeutic Exercise in Facial Nerve Palsy Rehabilitation: Pandemic Tips and Tricks

by Filippo Cavallaro, PT; Simona Portaro, MD, PhD; Teresa Pintaudi, PT; Mariachiara Ceccio, PT; and Angelo Alito, MD All authors are with the University of Messina in Messina, Italy. Funding: